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Abstract
Background: Despite the wide use of the Excited Component of the Positive and Negative Syndrome Scale
(PANSS-EC) in a clinical setting to assess agitated patients, a validation study to evaluate its psychometric
properties was missing.
Methods: Data from the observational NATURA study were used. This research describes trends in the use of
treatments in patients with acute psychotic episodes and agitation seen in emergency departments. Exploratory
principal component factor analysis was performed. Spearman’s correlation and regression analyses (linear
regression model) as well as equipercentile linking of Clinical Global Impression of Severity (CGI-S), Agitation and
Calmness Evaluation Scale (ACES) and PANSS-EC items were conducted to examine the scale’s diagnostic validity.
Furthermore, reliability (Cronbach’s alpha) and responsiveness were evaluated.
Results: Factor analysis resulted in one factor being retained according to eigenvalue ≥1. At admission, the PANSS-
EC and CGI-S were found to be linearly related, with an average increase of 3.4 points (p < 0.001) on the PANSS-EC
for each additional CGI-S point. The PANSS-EC and ACES were found to be linearly and inversely related, with an
average decrease of 5.5 points (p < 0.001) on the PANSS-EC for each additional point. The equipercentile method
shows the poor sensitivity of the ACES scale. Cronbach’s alpha was 0.86 and effect size was 1.44.
Conclusions: The factorial analyses confirm the unifactorial structure of the PANSS-EC subscale. The PANSS-EC
showed a strong linear correlation with rating scales such as CGI-S and ACES. PANSS-EC has also shown an
excellent capacity to detect real changes in agitated patients.
Background
Agitation and aggressive behaviour due to primary psy-
chiatric disturbances are particularly prevalent in emer-
gency psychiatric services and specialist psychiatric units
for acute psychoses [1]. During these emergency situa-
tions, some injuries to both patients and staff may
occur, and rapid and effective action is required to mini-
mize the risks [2]. A series of instruments are used in
clinical and research settings, allowing the rapid assess-
ment of the levels of aggression and anxiety in patients.
The preferred measure in modern trials is a subset of
items derived from the Positive and Negative Syndrome
Scale (PANSS) [3]. PANSS specifically assesses both
positive and negative symptoms of schizophrenia as well
as general psychopathology. To unravel the structure of
the PANSS items, a considerable number of factor ana-
lyses have been performed and most published studies
favour a five-factor solution: negative, positive, disorga-
nised (or cognitive), excited and depression/anxiety
factors [4,5].
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C o m p o n e n t( P A N S S - E C )i so n eo ft h es i m p l e s ta n d
most intuitive scales used to assess agitated patients [6].
The PANSS-EC consists of 5 items: excitement, tension,
hostility, uncooperativeness, and poor impulse control.
The 5 items from the PANSS-EC are rated from 1 (not
present) to 7 (extremely severe); scores range from 5 to
35; mean scores ≥ 20 clinically correspond to severe agi-
tation [7]. This set of items detects differences between
drug and placebo when evaluating acute agitation and
aggression in psychiatric patients [5,7-10] with different
psychiatric pathologies [7,8,11-18].
Despite its widespread use in research and clinical
practice, the PANSS-EC subscale has not been validated
against other established rating scales [19], nor for its
use in routine practice. Most information about its psy-
chometric properties comes from the global analysis of
the PANSS scale. Consequently it is important to know
the clinical meaning of its scores in daily clinical prac-
tice, outside the restrictions imposed by experimental
designs.
This study was designed to validate the PANSS-EC in
patients with acute psychosis and agitation through the
comparison of PANSS-EC ratings with ratings of the
Clinical Global Impression of Severity (CGI-S), the Clin-
ical Global Impression of Improvement (CGI-I) and the
Agitation and Calmness Evaluation Scale (ACES), in an
unselected sample of 278 patients who received oral
psychopharmacological treatment according to standard
clinical practice at emergency rooms in Spain.
Methods
Subjects and procedures
The study was conducted using data from NATURA, an
observational, naturalistic, multicentre, prospective study
designed to describe trends in the use of oral antipsy-
chotics and complementary treatments in patients with
acute psychotic episodes and agitation seen in emer-
gency departments [20,21]. Study participants were out-
patients aged 18 or older with acute psychosis and
agitation that according to investigators, required oral
psychopharmacological treatment at emergency room
units. Treatment was prescribed according to standard
clinical practice. Patients who had received treatment
with antipsychotics or benzodiazepines within 4 hours
prior to initial treatment, required intravenous drugs,
had a diagnosis of delirium or dementia, or were partici-
pating in any clinical trial, were excluded. Patients
admitted to a psychiatric emergency room during duty
service of investigators were consecutively enrolled.
Patients were observed from the time of admission to
the emergency room through discharge or transfer from
the psychiatric emergency service. Lack of improvement
made reintervention possible. Due to the observational
nature of the design all medical interventions performed
to control symptoms and agitation followed usual clini-
cal practice. The study was conducted according to the
Declaration of Helsinki guidelines and approved by the
regulatory authorities of Spain and by each centre’s
ethics committees.
Assessments
Demographic and admission data included age, sex,
average time from diagnosis to admission, diagnosis at
emergency room admission, and initial treatment. At
admission into the emergency room, agitated patients
were clinically assessed and received usual medical care.
If symptoms worsened or remained uncontrolled, an
additional pharmacological intervention ("reinterven-
tion”) was prescribed according to the usual medical
practice. Patients could either be discharged home or
admitted into hospital. Severity of agitation was assessed
according to the PANSS-EC, ACES and CGI-S at admis-
sion, before the first reintervention (if any) and at dis-
charge from the emergency room. All three scales were
administered at the same three described time points.
The improvement of agitation was also assessed by
CGI-I before the first reintervention (if any) and at dis-
charge to document the clinical changes that occurred
as a result of the pharmacological intervention.
CGI-S and CGI-I scales are well-recognized and estab-
lished psychometric instruments [22], suitable to mea-
sure the severity of agitation and its improvement or
worsening compared with the patient’s condition at
admission. The CGI-S assesses the clinician’s impression
of the current severity of agitation using scores from 1
(normal, not at all agitated) to 7 (among the most extre-
mely agitated patients). The CGI-I assesses the patient’s
improvement since the beginning of the study on a 7-
point scale ranging from 1 (very much improved) to 7
(very much worse). The CGI has been validated in psy-
chotic, mood and anxiety disorders. It has been con-
firmed as valid, reliable and sensitive to changes, and
presents the required profile for use as a clinical out-
come measure suitable for routine use [22,23].
The ACES consists of a single item that rates overall
agitation and sedation at the time of evaluation, where 1
indicates marked agitation; 2, moderate agitation; 3,
mild agitation; 4, normal behaviour; 5, mild calmness; 6,
moderate calmness; 7, marked calmness; 8, deep sleep;
and 9, unarousable. This scale has a high convergent
validity and high reliability [13,24] and has been used in
several clinical trials.
Statistical methods
Validity
According to current trends, measurement or test score
validation is an ongoing process wherein one provides
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and usefulness of the specific inferences made from
scores about individuals from a given sample in a given
context [25]. As Zumbo BD has pointed out, the feature
being validated is the inferences one makes from a mea-
sure assuming that inferences made from all empirical
measures, irrespective of their apparent objectivity, have
a need for validation. Therefore, validity depends on the
interpretations and uses of the test results and should
be focused on establishing the inferential limits of the
assessment, test or measure. Validity statements are not
dichotomic (valid/invalid), but rather described on a
continuum. They depend upon the cumulative informa-
tion that several studies have shielded on the topic. Vali-
dation practice has also evolved from a fragmented
approach to a comprehensive, unified approach in
which multiple sources of data are used to support an
argument. Validity, then is a unified concept, and valida-
tion is a scientific activity based on the collection on
multiple and diverse types of evidence [26].
From this perspective, and in order to assess the face
validity of the tool, a sample of eight psychiatrists with
expertise in treating schizophrenic patients with symp-
toms of agitation was asked to comment on the PANSS-
EC subscale. Psychiatrists were requested to evaluate
and provide their overall opinion on a series of ques-
tions about the readiness, suitability and feasibility of
the instrument. To determine the construct validity,
they were also asked about their impression of the
importance, frequency and clarity of each item on a 1 to
7 point scale. Correlation (Spearman’s) and regression
analyses (linear mixed models) as well as equipercentile
linking of the CGI-S, ACES and the PANSS-EC items
were conducted to examine the scale’sd i a g n o s t i c
validity.
The equipercentile linking is defined as a statistical
p r o c e s st h a ti su s e dt oa d j u s ts c o r e so nt e s tf o r m ss o
that scores on the forms can be interchangeable [27]. It
should be considered when alternate forms of tests
exist, scores on the alternate forms are to be compared,
and the alternate forms are built to the same detailed
specifications so that they are similar to one another in
content and statistical characteristics. In the psycho-
metric literature the term “linking” is referred to the
search of corresponding points on different, but corre-
lated, measurement devices. Different linking procedures
can be found in the literature [28,29], being the equiper-
centile procedure, the most accurate one. The algorithm
of this method is as follows: in the first step, percentile
rank functions are calculated for both variables. Using
the percentile rank function of one variable and the
inverse percentile rank function of the other, we find for
every score of one variable a score on the other variable
that has the same percentile rank. All these pairs of
scores are usually plotted in a graph, and connected by
a smooth curve that shows the equipercentile relation-
ship between the two forms. So each point in the graph
represents equivalent scores in both tests in the sense
that both scores share the same percentile rank in their
corresponding distributions.
In the current study we linked the PANSS-EC total
s c o r ea n dt h eC G I - Ss c o r ea sw e l lt h eP A N S S - E Ct o t a l
score and the ACES score at admission to and at dis-
charge from the emergency service. The LEGS statistical
programme (version 2.0) provided by The Center for
Advanced Studies in Measurement and Assessment of
the University of Iowa, College of Education http://
www.education.uiowa.edu/casma/index.html and based
on the Kolen & Brennan’s analysis (2004), has been
used. The relation between the CGI-I scale and the per-
centage PANSS-EC change from admission was also
assessed. A principal components factor analysis using
equamax rotation was performed to work out the struc-
ture of the PANSS-EC items in all patients of the sam-
ple and to explore the unidimensionality of the PANSS-
EC. The equamax rotation was chosen to be consistent
with many previous studies of the PANSS. The factor’s
extraction was consistent with the eigenvalue ≥ 1 rule.
Reliability
Cronbach’s alpha determination for measuring the inter-
nal consistency of the PANSS-EC and test-retest for
analysing its temporal consistency was carried out in all
patients. Chronbach’s alpha was determined at admis-
sion while test-retest was established at admission,
before pharmacological reintervention (if any) and at
discharge. Two groups of patients were defined accord-
ing to their clinical state during follow up in the emer-
gency room: 1) those patients who did not show any
changes in their overall state of agitation (CGI-I = 4)
before the pharmacological reintervention, and 2) those
patients who did show changes in their overall state of
agitation (CGI-I≠4) before the pharmacological reinter-
vention. Each time the patient was seen after medication
had been initiated at admission the clinician compared
the patient’s overall clinical condition to the one just
prior to the initiation of the pharmacological reinterven-
tion. The patient’s clinical condition was rated on a
seven-point scale as follows: “Compared to the patient’s
condition prior to medication initiation at admission,
this patient’s condition is: 1 = very much improved
since the initiation of treatment; 2 = much improved;
3 = minimally improved; 4 = no change from the initia-
tion of treatment; 5 = minimally worse; 6 = much
worse; 7 = very much worse since the initiation of treat-
ment”. CGI = 4 was chosen as the cut point measure
because it allows for differentiating those patients with
clinical changes from those who remained in the same
clinical state. It was expected that the CGI-I and the
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who remained in a similar clinical condition (CGI-I = 4).
In contrast, patients whose state of agitation changed sig-
nificantly following medications given at admission
would show lower correlation values with both scales.
The intraclass correlation coefficient (ICC) was deter-
mined for all cases distinguishing between the two
groups of patients: those who required pharmacological
reintervention and those who did not. The ICC was cal-
culated for each group. Aditionally, Wilcoxon’ss i g n e d
rank test was applied to compare admission and retest
medians. In most studies, to evaluate the reliability and
stability of any test, a test-retest comparison procedure is
performed. This test-retest comparison can be done by
using a paired t-test to compare the mean response in
both moments, or by using a Wilcoxon test to compare
the medians. Due to the characteristics of the scale used,
we have preferred to perform a test-retest analysis by
comparing the medians, instead of comparing the means.
Responsiveness
For its use in clinical trials, the PANSS-EC should be
capable of detecting changes in the clinical condition of
the patients that may occur over time, preferably at
more than one time-point in order to understand the
onset and durability of the effect [30]. In this sense,
responsiveness provides additional evidence of the valid-
ity of an instrument, and it was measured using the
effect size (ES) which gives a continuous parametric
measure of the change between admission and follow-
up and can be easily interpreted [31-34].
Results
A total of 278 patients were enrolled in the study (309
screened). The average length of stay at the emergency
service before pharmacological reintervention was
2 hours 50 minutes (standard deviation (SD) 4 hours
7 minutes), and a median length of 1 hour 28 minutes.
The total average length of stay at the emergency service
was 4 hours 23 minutes (SD 6 hours 42 minutes) and a
median of 1 hour 53 minutes. A detailed description of
sample demographic and clinical characteristics has
been published elsewhere [20,21].
PANSS-EC scores
For all patients (n = 278), the mean PANSS-EC total
scores (SD) decreased progressively from 20.38 points
(SD 5.07) at entry to 13.07 points (SD 5.45) at discharge.
For each item, except for hostility and lack of coopera-
tion, the most frequently reported categories were mod-
erate and fairly severe at admission, and minimum and
mild at discharge (Table 1).
CGI-S scores
At admission, 62.6% of patients displayed mildly or
moderately agitated behaviour. The highest proportion
(83.1%) of patients was found to have a CGI-S score in
the range of 3 ("mildly agitated”) to 5 ("markedly agi-
tated”) points. At discharge, 33.2% of patients showed
mildly or moderately agitated behaviour while the vast
majority (85.7%) of patients had a 1 ("normal, not at all
agitated”) to 3 ("mildly agitated”) points CGI-S score
(Table 2).
ACES scores
At admission, 90.6% of patients displayed mild or mod-
erate agitation and at discharge, 47.1% of patients
showed mild or moderate agitation (Table 2). Normal
behaviour changed from 0.7% at admission to 38.6% of
patients at discharge.
A significant number of patients (n = 106, 38.1%)
required a pharmacological reintervention at the emer-
gency department. For this subset of patients, at the
time of the pharmacological reintervention, the PANSS-
EC average score was 20.04 (SD 5.76). The CGI-S
scores, on the other hand, showed that 30.8% of the
patients were markedly agitated and 22.4% were severely
agitated. The CGI-I scores showed that 45.8% of the
patients requiring pharmacological reintervention were
Table 1 Percentage of patients in each category of the PANSS-EC scale at admission (n = 278), in case of
reintervention (n = 106) and at discharge (n = 278)
Poor impulse control Tension Hostility Lack of cooperation Excitement
ARD A R D A R D ARD A R D
Absent 0.4 3.7 18.6 0.4 — 13.9 7.2 7.5 33.9 7.2 6.5 31.8 0.4 1.9 19.3
Minimal 6.1 7.5 25 1.8 7.5 29.3 14.4 18.7 18.2 9.7 14 19.3 1.8 4.7 26.8
Mild 17.6 22.4 28.6 14.7 15 26.8 22.7 17.8 28.9 26.3 16.8 27.1 16.5 19.6 32.1
Moderate 40.6 26.2 22.1 36.7 32.7 21.4 28.4 26.2 14.3 25.9 29 12.9 40.3 35.5 17.1
Moderate-severe 20.1 30.8 3.9 26.6 31.8 7.5 14.7 16.8 3.6 18.7 16.8 6.8 25.9 23.4 3.2
Severe 9.7 6.5 1.8 18 10.3 0.7 9.7 8.4 1.1 8.6 11.2 1.8 12.6 11.2 1.4
Extremely severe 1.8 1.9 — 1.8 1.9 0.4 2.9 3.7 — 3.6 4.7 0.4 2.5 2.8 —
PANSS-EC: Excited Component of the Positive and Negative Syndrome Scale; A: admission; R: reintervention; D: discharge.
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unchanged (CGI-I = 4) at the time of the reintervention
( c o m p a r e dt os c o r e sa ta d m i s s i o n ) .T h eA C E Ss c o r e
showed moderate agitation in 49.5% of the patients and
mild agitation in 30.8%.
The Wilcoxon’s test showed that the medians change in
the agitation score between admission and discharge was
statistically significant (p < 0.0001) for all scales: PANSS-
EC (-14.54), CGI-S (-13.3) and ACES (-13.02). Changes
were also statistically significant in those patients requiring
a pharmacological reintervention: PANSS-EC (-5.97), CGI-
S (-4.36) and ACES (-4.21). These results showed that the
scales detected differences in the state of agitation in most
patients between admission and discharge.
Validity
Experts found that the scale eased their assessment of the
intensity of agitation in patients with acute psychotic epi-
sodes, and their follow up. They considered the PANSS-
EC useful. The analysis of the importance, frequency and
clarity of each individual item on a 5 point scale showed
a mean value between 4 and 5 for most items except for
clarity in the tension, lack of cooperation and excitement
items which showed a 3.33 mean value (SD 0.57).
Spearman’s correlation coefficients between the
PANSS-EC and the CGI-S scales were r = 0.73 (p <
0.001) at admission and r = 0.8 (p < 0.001) at discharge
(n = 278), and r = 0.76 (p < 0.001) amongst those
patients requiring a pharmacological reintervention (n =
106). Correlations between PANSS-EC and ACES were
r = -0.73 (p < 0.001) at admission, r = -0.71 (p < 0.001)
at discharge (n = 278), and r = -0.79 (p < 0.001)
amongst those patients requiring a pharmacological
reintervention (n = 106). Correlations for the PANSS-
EC items varied between 0.64 for lack of cooperation
and 0.26 for excitement (p < 0.01) between admission
and discharge.
At admission, the PANSS-EC and CGI-S were found to
be linearly related, with an average increase of 3.4 points
(p < 0.0001) on the PANSS-EC for each additional CGI-S
point (Figure 1a). At discharge, the relationship between
t h eP A N S S - E Ca n dC G I - Sw a sa l s of o u n dt ob el i n e a r
with an average increase of 3.7 points (p < 0.001) on the
PANSS-EC for each additional CGI-S point. In a linear
model, the CGI-S score explained 66.7% of the variance
of the PANSS-EC total score for all patients. Both ques-
tionnaires were measured with random error and results
were presented in a categorical scale. Considering that a
regression analysis usually requires a normal distribution
of the data and assumes linearity, in this study, the equi-
percentile linking was also represented to find out con-
cordance as well as prediction amongst data, and to
achieve more comparable scores [35]. The PANSS-EC
a n dC G I - Ss c o r ea ta d m i s s i o na n da td i s c h a r g ew e r e
linked and presented (Figure 2a). CGI scores were linked
to PANSS scores at admission: 1 = 5-11, 2 = 12-14, 3 =
15-19, 4 = 20-23, 5 = 24-27, 6 = 28-32. The PANSS-EC
and ACES were found to be linearly and inversely related,
with an average decrease of 5.5 points (p < 0.0001) on the
PANSS-EC for each additional ACES point (Figure 1b).
Using the equipercentile linking method, the poor sensi-
tivity of the ACES scale and its poor capacity for discri-
minating values that imply sedation (ACES = 5 to 9)
seems evident as well as its tendency to a ceiling effect
for agitation scores in patients admitted to emergency
rooms (Figure 2b). However, the small percentage of
markedly sedated patients (ACES ≥ 7) at discharge makes
it difficult to guarantee the sensibility of the ACES in this
sample.
The relationship between the PANSS-EC percentage
change from admission and CGI-I score at discharge
was inverse and linear, with a decrease of 17.98 points
(p < 0.001) on the PANSS-EC for each additional CGI-I
point (Figure 3). To estimate these ratios the minimal
value of 5 was subtracted. The CGI-I score explained
4.6% of the variance (CGI-I ratings of 6 and 7 were not
included because of under-representation). Ratings of
very much improved corresponded to median reduction
of 58% on PANSS-EC; ratings of much improved corre-
sponded to median reduction of 38% on PANSS-EC;
and ratings of minimally improved corresponded to
median reduction of 18% on PANSS-EC.
Table 2 Percentage of patients in each category of the
CGI-S and ACES scales at admission, in case of
reintervention and at discharge
Admission Reintervention Discharge
CGI-S
Normal 0 0.9 39.3
Borderline agitated 10.1 2.8 23.2
Mildly agitated 29.1 12.1 23.2
Moderately agitated 33.5 19.6 10
Markedly agitated 20.5 30.8 3.2
Severely agitated 6.1 22.4 0.7
The most extremely agitated 0.7 11.2 0.4
ACES
Marked agitation 8.3 12.1 1.4
Moderate agitation 49.6 49.5 11.4
Mild agitation 41.0 30.8 35.7
Normal behaviour 0.7 5.6 38.6
Mild calmness 0.4 0.9 8.2
Moderate calmness ——1.4
Marked calmness ——2.1
Deep sleep ——0.7
Not valuable ——0.4
CGI-S: Clinical Global Impression of Severity; ACES: Agitation and Calmness
Evaluation Scale.
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Figure 1 a. Distribution of the PANSS-EC total scores at patient’s admission corresponding to CGI-S values for all patients (unadjusted
data). Box = 25% and 75% quartiles, line = median, whiskers = minimum and maximum values, circles = outliers. Note: no participants gave a
score of 1 in the CGI-S at admission. PANSS-EC: Excited Component of the Positive and Negative Syndrome Scale; CGI-S: Clinical Global Impression
of Severity. b. Distribution of the PANSS-EC total scores at patient’s admission corresponding to ACES values for all patients (unadjusted data).
Box = 25% and 75% quartiles, line = median, whiskers = minimum and maximum values, circles = outliers. PANSS-EC: Excited Component of the
Positive and Negative Syndrome Scale; ACES: Agitation and Calmness Evaluation Scale.
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Figure 2 a. Linking of CGI-S with the PANSS-EC score at admission (green line) and at discharge (blue line).T h eg r a p hp l o t st h e
corresponding (real) CGI score for every (integer) PANSS-EC score. For the reverse direction, the intersection of the lines indicates an integer CGI
value with the graph providing the corresponding PANSS-EC score. PANSS-EC: Excited Component of the Positive and Negative Syndrome Scale;
CGI-S: Clinical Global Impression of Severity. b. Linking of ACES with the PANSS-EC score at admission (blue line) and at discharge (green line).
The graph plots the corresponding (real) ACES score for every (integer) PANSS-EC score. For the reverse direction, the intersection of the lines
indicates an integer ACES value with the graph providing the corresponding PANSS-EC score. PANSS-EC: Excited Component of the Positive and
Negative Syndrome Scale; CGI-S: Clinical Global Impression of Severity.
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retained according to eigenvalue ≥ 1 criteria. The var-
iance explained by the factor was 64.43% and the five
items exceeded the loading 0, 74. The correlation matrix
is represented in Table 3. These findings confirmed the
unidimensinality of the PANSS-EC.
Reliability
Cronbach’s alpha coefficient was 0.86. Before pharmaco-
logical reintervention, when psychiatrists reported no
changes on patient’s agitation state, the Intraclass Corre-
lation Coefficient (ICC) was 0.9 (PANSS-EC total score),
and before discharge from the emergency room, when
psychiatrists reported no changes on patient’s agitation
state (ICG-I = 4, n = 17), ICC was 0.8 Due to the limita-
tions of this measurement, we can only estimate the
reliability through the ICC on those patients whose true
score does not change over the time period analyzed,
i.e. in the group of patients where CGI = 4. In a recent
papers, Laenen A and Alonso A [36,37] proposed a new
measurement for reliability of a rating scale, based on
the classical definition of reliability, as the ratio of the
true score variance and the total variance, which is esti-
mated from the covariance parameters obtained from a
linear mixed model. As we have just fitted a classical
linear regression model, we will take into account this
measurement in future works.
Figure 3 Distribution of the percentage of reduction in the PANSS-EC score corresponding to CGI-I values from baseline to discharge
for all patients (unadjusted data). Box = 25% and 75% quartiles, line = median, whiskers = minimum and maximum values, circles = outliers.
PANSS-EC: Excited Component of the Positive and Negative Syndrome Scale; CGI-S: Clinical Global Impression of Severity.
Table 3 Correlation matrix of the PANSS-EC scale
Poor impulse control Tension Hostility Uncooperativeness Excitement
Poor impulse control 1.000
Tension 0.517 1.000
Hostility 0.603 0.602 1.000
Uncooperativeness 0.647 0.504 0.649 1.000
Excitement 0.546 0.576 0.448 0.451 1.000
PANSS-EC: Excited Component of the Positive and Negative Syndrome Scale.
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The magnitude of the change in PANSS-EC scores
between patients’ admission and discharge from the
emergency service was large (ES = 1.44); it was smaller
between patients’ admission and reintervention (ES =
0.46). The PANSS-EC was capable of detecting changes
of different magnitude at different time-points. As
expected, the magnitude of the change in the agitation
state of patients was larger from admission to discharge
than from admission to follow up in the emergency
room when a pharmacological intervention was needed.
Discussion
The PANSS-EC is a commonly used instrument, to
assess severely aggressive and agitated patients; however,
it has not yet been validated against other recognized
scales. According to the authors’ best knowledge, this is
the first article reporting a specific validation of the
PANSS-EC as an instrument independent from the
PANSS scale and against established rating scales such
as the CGI-S or the ACES [13].
Several studies have assumed PANSS-EC validity
based on data from the original PANSS study conducted
by Kay et al. (1987) and used in multiple trials
[10,12,14,38]. Huber et al. (2008) [39], for instance, car-
ried out a validation study of the Clinical Global
Impression Scale for Aggression (CGI-A) in psychiatric
patients seen in the emergency room using the PANSS-
EC subscale as the comparative instrument. The CGI-A
has been derived from the CGI-S scale which was
designed as an overall measure of illness severity in psy-
chiatric disorders. The CGI-A specifically measures
aggression rather than allowing for a global assessment
of the psychiatric state of patients.
Most of the studies that have explored the factorial of
the PANSS are based on data coming from clinical
trials. In the present study, we used data from an obser-
vational study in patients with acute psychotic episodes
and agitation who entered the emergency service, a sam-
ple of patients treated in routine clinical practice
settings.
The factorial analysis confirms the unifactorial struc-
ture of the PANSS-EC subscale with the five suggested
items. The variance, explained as the matrix of compo-
nents, confirms the robustness of the separated use of
the excitement component of the PANSS. The Cron-
bach’s alpha coefficient was higher than the established
standards and superior to other coefficients reported in
recent studies analysing factorial structure of the whole
PANSS [5]. Being a unidimensional and consistent tool
with highly correlated scores, the PANSS-EC allow for
acceptably assessing agitated patients. Another report
[6] identifies a cluster of mania-like symptoms through
the use of PANSS-based factor analysis of data pooled
from three patient samples. This factor shows good
internal reliability. That report, however, only considers
four items and leaves out the tension item that has a
higher weight in the depression subscale.
The ICC informs about the desirable behaviour of the
scale considering that the internal consistency is higher
when the state of agitation of patients does not change
in an opposed way. The sensitivity of the scale assessed
through the floor and ceiling effect is adequate. Less
than 7.2% of the patients reported the minimum score
and 3.5% the maximum score. The correlation between
PANSS-EC and CGI-S total scores was high (r = 0.73-
0.83). Correlations between the PANSS-EC and the
ACES scales were equally high (r = -0.73, -0.71). These
results are similar to those reported by other authors.
For instance, Huber et al. (2008) found correlations
between the CGI-S and the PANSS-EC scales of 0.83;
Meehan et al. (2002) reported an r = -0.71 between the
PANSS-EC and the ACES scales; Leucht et al. (2005)
[40] reported coefficients of 0.56 and 0.73 between the
PANSS-EC and CGI-S scales. Using the entire PANSS,
Levine et al. (2008) found correlations of r = 0.61 to r =
0.73 between the same scales. The ACES specificity for
measuring agitation in psychiatric patients explains the
ceiling effect found in this study of agitated patients.
Parallelism between the study by Huber et al. (2008)
and ours is worth noting. In both studies there is a lin-
ear relation between the two instruments as well as an
increase in the scoring of the PANSS-EC for each point
considered of the CGI-S scale. While our results show
that scores increase 3.4 points, Huber’s study reports
4.6. However the increase estimates are not directly
comparable between studies, because they used a CGI-S
version with five levels of responses while we used the
original version of seven options.
The responsiveness result that we have obtained is
excellent and provides additional evidence of the validity
of PANSS-EC. One of the most interesting findings of
the validation process of the PANSS-EC subscale has
been the quantification of the reductions on the scoring
system of the scale, which correlates well with states of
agitation, such as minimally improved (18%), much
improved (38%) and very much improved (58%). These
similarities with the CGI-I scale suggest an improve-
ment in patients’ agitated state and they could be taken
as the minimum clinically significant differences.
Strengths and limitations
The large sample study of psychotic patients with an
episode of agitation contributes to the external validity
of these results. Analysis shows that this is an adequate
and useful instrument for assessment of agitated and
aggressive patients. Limited ceiling effects are unlikely to
limit the generalizability of results, since PANSS-EC
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ing scales such as CGI-S and ACES (particularly with
the ACES). PANSS-EC has also shown an excellent
capacity to detect real changes in agitated patients.
Changes in percentages represent improvements in
health status that can be detected, measured and con-
firmed. In order to overcome methodological concerns
against linear regression analysis and equipercentile link-
ing, we use both to assess the relation amongst the
PANSS-EC, the CGI-S and the ACES scales.
The short follow-up period is amongst the main study
limitations. Given the naturalistic character of the study,
we have focused on the time patients stay in the emer-
gency service, which is usually very short. This brief
follow-up period may have possibly influenced the test-
retest reliability. Nevertheless, the ES test offers a very
good result, showing that the instrument holds a great
sensitivity to changes. Intermediate assessments of those
patients requiring pharmacological reintervention have
been conducted very shortly after admission, and
changes in the state of patients’ agitation may not be
significant enough as to find differences. Another possi-
ble study limitation is a treatment bias. We excluded
patients on intravenous medications because many of
them frequently perceive the intravenous route to be
compulsory. These perceptions may negatively affect the
patient-doctor relationship and may have some bearing
on treatment adherence and follow-up by restraining
patients’ contribution to the therapeutic plan [21].
It is important to mention the conceptual barriers
when referring to agitation and aggression. Agitation is
still a poorly understood phenomenon. The absence of a
clear definition of the syndrome is associated with pro-
blems to measure it. Agitation may appear in the con-
text of almost any severe psychiatric disorder, and its
features may vary greatly according to the underlying
condition. Moreover, cultural differences have also been
suspected of producing significant differences in the dis-
play of agitation. These features, which are inherent to
the disease being explored, together with the design of
the study (observational) and the type of patients (agi-
tated) being assessed, make it highly improbable to
avoid all possible bias. Furthermore, in our study, the
same clinician assessed each patient’s agitation using dif-
ferent scales. This may have led to overestimate the sta-
tistical correlations.
Conclusions
Despite the wide use of the PANSS-EC scale, a valida-
tion study to inform on its psychometric properties was
missing. The goal of this study has mainly focused on
filling in this gap. The present results show PANSS-EC
has a good sensitivity; without either ceiling or floor
effect; with an acceptable Cronbach’sa l p h aa n da n
optimal temporal stability. The factorial analysis has
revealed a unifactorial structure and the responsiveness
has shown excellent results. These results are even more
s i g n i f i c a n ti ft h es h o r tp e r i o do ft i m et h a tp a t i e n t s
stayed in emergency room is taken into account.
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